SANUWAVE Health's Bold Move in the Market
SANUWAVE Health, Inc. (NASDAQ: SNWV), a pioneering company in the development of advanced wound care products, is set to make a momentous change to its common stock with a reverse stock split. This strategic move aims to optimize the company’s position in the competitive health sector and enhance shareholder value.
The Details of the Reverse Stock Split
Effective at 12:01 a.m. Mountain Time, the company will enact a 1-for-375 reverse stock split. This means that for every 375 shares currently held, shareholders will receive 1 new share, thereby reducing the total number of outstanding shares drastically from approximately 1.18 billion to around 3.15 million shares. This split is expected to commence trading on a split-adjusted basis on the OTCQB under the ticker symbol “SNWV” shortly thereafter.
Adjustment of Shareholders' Holdings
This reverse stock split reflects SANUWAVE's strategy to decrease the number of shares while maintaining the proportional ownership percentage of its investors. All outstanding equity awards, convertible notes, and warrants will also be adjusted accordingly to maintain fairness among investors.
What This Means for Investors
For stockholders, this is a crucial moment. On the effective date of the split, all shares of common stock will be automatically condensed, meaning that no action is necessary for current shareholders. However, stockholders will receive a transaction statement detailing the exchange of current shares for the new post-split shares.
Stock Certificate Exchange Process
For those holding physical stock certificates, SANUWAVE has partnered with Securities Transfer Corporation (STC) as the exchange agent. STC will provide all necessary guidance on how to exchange old shares for new ones following the split. Any queries regarding the process can be directed to STC at their contact number.
About SANUWAVE Health
SANUWAVE is committed to revolutionizing wound care with its innovative medical systems that activate biological responses in a non-invasive manner to facilitate skin, tissue, and vascular recovery. With a focus on research and development, the company’s comprehensive range of regenerative medicine products is designed to support the natural healing processes in various medical applications.
The effectiveness of SANUWAVE's technologies is being explored in areas such as wound healing, orthopedic applications, cosmetic treatments, and cardiac functions, illustrating the broad impact and potential of its technologies on the future of healthcare.
Frequently Asked Questions
What is the purpose of SANUWAVE's reverse stock split?
The reverse stock split aims to consolidate shares and improve the company's stock price, making it more attractive to investors.
How will this affect current shareholders?
Current shareholders will see their total number of shares decrease, but their percentage ownership in the company will remain unchanged.
When will the reverse stock split take effect?
The split will take effect on October 18, 2024, at 12:01 a.m. Mountain Time.
What should stockholders holding certificates do?
Stockholders with physical certificates will receive information from STC regarding the exchange process for their shares.
Who can I contact for further questions regarding my shares?
For any questions related to the reverse stock split, shareholders can contact Securities Transfer Corporation at (469) 633-0101.
